A PYMNTS Company

Antitrust remedies: in search of a balanced dosage

 |  October 2, 2017

By Eduardo Caminati Anders & Guilherme Teno Castillho Misale

The assessment of antitrust remedies under the merger control realm has been raising noteworthy reflections worldwide, and one clear-cut challenge in this strand concerns the gauging of remedies to achieve an adequate and balanced dosage so as to avoid perverse effects. Ultimately, the remedy can turn itself into poison (sola dosis facit venenum) if not well-structured.

Download Full Article: Here

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.